Tata Steel: The company reported an 87% year-on-year decline in consolidated net profit at Rs 1,514 crore in Q2FY23, against Rs 11,918 in the corresponding quarter the year ago. Revenue was flat at Rs 59,878 crore. The production for the quarter was down 3% on-year and deliveries were down 2%. EBITDA per ton dipped 60% year-on-year to Rs 6,060.4 crore. The slowdown in major economies around the globe and uncertain geopolitical issues combined with seasonal factors led to an unfavourable operating environment during the quarter.

Also Read: Twitter delisted from New York Stock Exchange after Elon Musk acquisition

Larsen & Toubro: L&T reported performance for Q2FY23 registering 22.5% year-on-year growth in net profit to Rs 2,229 crore. Consolidated revenue grew 23% to Rs 42,763 crore led by execution tailwinds in the infrastructure projects segment and sustained growth momentum in the IT & TS portfolio. The company secured orders worth Rs 51,914 crore during the reviewed quarter, a year-on-year growth of 23%. The consolidated order book of the group was at Rs 372,381 crore as of quarter-end.

Also Read: Binance’s CZ confirms $500 million investment in Elon Musk’s Twitter deal

Castrol India: The lubes company reported a flat growth in its net profit of Rs 187 crore. While the revenue from operations rose 4% to Rs 1,121 crore. The performance was impacted due to forex and inflationary pressures, which led to higher costs of additives and base oil.

Also Read: Did Jair Bolsonaro’s cannibal rhetoric, I’d eat an Indian remark, lose him Brazil polls?

Glenmark Pharmaceuticals: Glenmark Pharmaceuticals Inc (USA) launched Fingolimod capsules, 0.5 mg, which is the generic version of Gilenya1 Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation. According to IQVIA data for the 12-month period ending September 2022, the Gilenya Capsules, 0.5 mg market reached annual sales of around $1.8 billion.

Also Read: India’s job situation ‘really alarming’: Raghuram Rajan

Data Patterns: Data Patterns reported a net profit for Q2FY23 at Rs 21 crore, a growth of 63% driven by the efficiencies in operating costs. The total revenue reported was Rs 90 crore, up by 51%. The company has Rs 884 crore worth of orders in books.

Also Read: ECB announces super rate hike of 75 bps to combat inflation

GHCL Limited: The chemicals company reported a 212% on-year growth in its net profit to Rs 289 crore against Rs 93 crore a year ago. The standalone revenue was at Rs 1,389 crore, up 73% driven by the doubling of its inorganic chemicals business. Revenue grew by 98% on-year to Rs 1,130 crore. EBITDA was at Rs 442 crore, up  159%.

Also Read: Bank of Japan keeps ultra-low interest rates at -0.1%

Equitas Small Finance Bank: The small finance bank reported a net profit of Rs 116 crore Q2FY23, up 183% year-on-year. Net interest income for the quarter was at Rs 610 crore, up 26% year-on-year. Gross advances at Rs 22,779 crore as of September FY23, up by 20% year-on-year and disbursement at Rs 3,845 crore, up by 22% year-on-year.